• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Cerephex

edit

Cerephex is a company developing its proprietary RINCE technology for treatment applications involving noninvasive brain stimulation. Cerephex is currently engaged in development activities aimed at gaining FDA approval of its NeuroPoint device for the management of fibromyalgia, a chronic pain condition that involves abnormal central pain processing mechanisms.

Recent Milestones

edit

• 
  Cerephex received () in Series A funding. (10/12/12)
  Posted 10/13/12 at 2:03am via dowjones.com
• 
  Cerephex added Rob Ford as Founder, CEO.
  Posted 4/27/13 at 5:53am

Videos

Screenshots

edit

Above: Cerephex
Uploaded: 10/13/12

Sources

1. Neurostim Device Maker Cerephex Raises Series A Tranche for Trials (pevc.dowjones.com) [edit]